polynovo signed contract sale aod9604 lateral pharma PharmNovo enhances its Board ahead of Phase II development SN 1125 Memorandum of Land
SN 1125 Memorandum of Land Sale Contract (OR) AOD 9604 Simon's Compounding Cancer R&D Partnerships, M&A and Venture Funding by Tech Q3 2025 Review DealForma Innoveix Pharmaceuticals, Inc. Issues Voluntary Recall of All Sterile Compounded Drug Products Due to A Lack of Sterility Assurance FDA
Pay in 4 interest-free payments of $5.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



